However, since PTEN modulates a variety of biological processes, an increasing number of studies have investigated the changes in PTEN in the context of non-neoplastic digestive diseases such as hepatitis, colitides, pancreatitis, hepatic insulin resistance, and liver fibrosis. This evidence concerns the gene PTEN and Insulin resistance.